Key result
Among women referred to cardiac rehabilitation, treatment for psychosocial distress was received by less than half of those with elevated symptoms and was not significantly associated with reduced depressive symptoms at 6 months.
Why the study?
Does treatment for psychosocial distress improve depressive and anxious symptoms at 6 months in women referred to cardiac rehabilitation?
Observational (n=191)
Yes
Does treatment for psychosocial distress improve depressive and anxious symptoms at 6 months in women referred to cardiac rehabilitation?
In women with cardiovascular disease referred to cardiac rehabilitation, psychosocial distress is highly prevalent but under-treated, and current treatment approaches may not adequately relieve symptoms.
Answers are grounded in this paper and cite their sources.
Treatment receipt showed no symptom benefit in this cohort; leaves open whether targeted screening improves outcomes in women referred to cardiac rehab.
BACKGROUND: Cardiovascular disease (CVD) is one of the leading causes of morbidity and mortality among women. Women with CVD experience a greater burden of psychosocial distress than men, and practice guidelines promote screening in cardiac patients, especially women. The objectives herein were to describe the burden of psychosocial distress, extent of screening, forms of treatment, and whether receipt of treatment was related to psychosocial distress symptom severity at follow-up, among women. METHODS: Within a multi-center trial of women randomized to cardiac rehabilitation models, consenting participants were asked to complete surveys upon consent and 6 months later. Clinical data were extracted from charts. This study presents a secondary analysis of the surveys, including investigator-generated items assessing screening and treatment, the Beck Depression Inventory-II, the Hospital Anxiety and Depression Scale, and Patient Health Questionnaire-2. RESULTS: Of the 128 (67.0%) participants with valid baseline and follow-up survey results, 48 (40.3%) self-reported that they recalled being screened, and of these, 10 (21.3%) recalled discussing the results with a health care professional. Fifty-six (43.8%) retained participants had elevated symptoms of psychosocial distress at baseline, of which 25 (44.6%) were receiving treatment. Regression analyses showed that treatment of psychosocial distress was not significantly associated with follow-up depressive symptoms, but was significantly associated with greater follow-up anxiety. CONCLUSIONS: Findings reiterate the great burden of psychosocial distress among women with CVD. Less than half of patients with elevated symptoms were treated, and the treatment approaches appeared to insufficiently achieve symptom relief.
No takes yet. Share an insight, caveat, or question.
Hurley et al. (2017) conducted an observational in Cardiovascular disease with depressive or anxious symptoms (n=191). Psychosocial distress treatment (pharmacotherapy or psychotherapy) vs. No treatment was evaluated on Depressive symptom severity at follow-up (HADS-D) (β -0.636, 95% CI -3.677 to 2.404, p=0.673). Among women referred to cardiac rehabilitation, treatment for psychosocial distress was received by less than half of those with elevated symptoms and was not significantly associated with reduced depressive symptoms at 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: